cbdMD (YCBD) Acquisitions (2018 - 2019)

cbdMD (YCBD) reported Acquisitions of -$250740.0 for Q3 2019, down 2271.74% sequentially from -$10572.0 in Q2 2019.

cbdMD (YCBD) Acquisitions (2018 - 2019) Analysis & Trends

cbdMD (YCBD) has 2 years of Acquisitions data on file, last reported at -$250740.0 in Q3 2019.

For the quarter ending Q3 2019, Acquisitions changed N/A year-over-year to -$250740.0; the trailing twelve-month figure through Jun 2020 stood at -$250740.0 (down 121.48% YoY), and the FY2019 full-year result was $916555.0, changed N/A from the prior year.
Acquisitions eased to -$250740.0 in Q3 2019, from -$10572.0 in the prior quarter.
In the past five years, Acquisitions ranged from a high of $1.2 million in Q4 2018 to a low of -$250740.0 in Q3 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	cbdMD	438,678.80	-2.95 Mn	3.00 Mn	-

Download Data